Evrofarma SA (EVROF.AT)
EUR 1.89
(0.53%)
EUR 1.89
(0.53%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 12.51 Million EUR | -22.43% |
| 2022 | 16.12 Million EUR | -10.7% |
| 2021 | 18.06 Million EUR | 8.59% |
| 2020 | 16.63 Million EUR | 2420.3% |
| 2019 | 660 Thousand EUR | -93.36% |
| 2018 | 9.94 Million EUR | 638.08% |
| 2017 | 1.34 Million EUR | -88.16% |
| 2016 | 11.37 Million EUR | -21.56% |
| 2015 | 14.5 Million EUR | -9.01% |
| 2014 | 15.93 Million EUR | 11.48% |
| 2013 | 14.29 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 10.85 Million EUR | 0.0% |
| 2023 Q2 | 15.24 Million EUR | 0.0% |
| 2023 Q1 | 15.24 Million EUR | -5.84% |
| 2023 FY | 12.51 Million EUR | -22.43% |
| 2023 Q4 | 12.51 Million EUR | 0.0% |
| 2023 Q3 | 12.51 Million EUR | -17.95% |
| 2022 Q1 | 17.95 Million EUR | -0.61% |
| 2022 Q3 | 16.19 Million EUR | -9.79% |
| 2022 Q4 | 16.19 Million EUR | 0.0% |
| 2022 FY | 16.12 Million EUR | -10.7% |
| 2022 Q2 | 17.95 Million EUR | 0.0% |
| 2021 Q3 | 18.06 Million EUR | -2.86% |
| 2021 Q1 | 18.59 Million EUR | 11.81% |
| 2021 FY | 18.06 Million EUR | 8.59% |
| 2021 Q2 | 18.59 Million EUR | -0.02% |
| 2021 Q4 | 18.06 Million EUR | 0.0% |
| 2020 Q3 | 16.64 Million EUR | 13.14% |
| 2020 Q2 | 14.7 Million EUR | -0.06% |
| 2020 Q1 | 14.71 Million EUR | 2129.85% |
| 2020 Q4 | 16.63 Million EUR | -0.04% |
| 2020 FY | 16.63 Million EUR | 2420.3% |
| 2019 Q1 | 9.35 Million EUR | -5.86% |
| 2019 FY | 660 Thousand EUR | -93.36% |
| 2019 Q2 | 9.32 Million EUR | -0.38% |
| 2019 Q4 | 660 Thousand EUR | -3.37% |
| 2019 Q3 | 683 Thousand EUR | -92.67% |
| 2018 FY | 9.94 Million EUR | 638.08% |
| 2018 Q4 | 9.94 Million EUR | 0.0% |
| 2018 Q2 | 1.25 Million EUR | 0.0% |
| 2018 Q1 | 1.25 Million EUR | -9.25% |
| 2018 Q3 | 9.94 Million EUR | 691.56% |
| 2017 Q4 | 1.38 Million EUR | 0.0% |
| 2017 Q1 | 9.71 Million EUR | -15.19% |
| 2017 Q2 | 9.71 Million EUR | 0.0% |
| 2017 FY | 1.34 Million EUR | -88.16% |
| 2017 Q3 | 1.38 Million EUR | -85.76% |
| 2016 Q2 | 13.6 Million EUR | 0.0% |
| 2016 Q1 | 13.6 Million EUR | -6.85% |
| 2016 FY | 11.37 Million EUR | -21.56% |
| 2016 Q4 | 11.45 Million EUR | 0.0% |
| 2016 Q3 | 11.45 Million EUR | -15.79% |
| 2015 Q2 | 15.78 Million EUR | -2.53% |
| 2015 FY | 14.5 Million EUR | -9.01% |
| 2015 Q1 | 16.18 Million EUR | 0.45% |
| 2015 Q3 | 15.8 Million EUR | 0.18% |
| 2015 Q4 | 14.6 Million EUR | -7.62% |
| 2014 Q1 | 14.14 Million EUR | -1.05% |
| 2014 Q3 | 16.71 Million EUR | 2.77% |
| 2014 Q4 | 16.11 Million EUR | -3.59% |
| 2014 FY | 15.93 Million EUR | 11.48% |
| 2014 Q2 | 16.26 Million EUR | 14.99% |
| 2013 Q2 | 1.27 Million EUR | -3.91% |
| 2013 Q4 | 14.29 Million EUR | -4.62% |
| 2013 FY | 14.29 Million EUR | 0.0% |
| 2013 Q1 | 1.32 Million EUR | 0.0% |
| 2013 Q3 | 14.99 Million EUR | 1073.84% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Flour Mills Kepenos S.A. | 22.25 Million EUR | 43.766% |
| Kri-Kri Milk Industry S.A. | 10.23 Million EUR | -22.307% |
| Loulis Food Ingredients S.A. | 35 Million EUR | 64.253% |